17-Mar-2011 - instrAction GmbH

instrAction and Protagen Form Strategic Alliance

instrAction GmbH and Protagen AG signed a strategic alliance for the development of customized instrAction® Phases for downstream processing of biotherapeutics.

“The instrAction® Phases are proprietary synthetic chromatography phases which show excellent performance compared to commonly used matrices for e.g. antibody purification. The unique know-how and expertise of Protagen in GMP-compliant protein analysis and related services will be decisive for the development of a portfolio of new tailor made separation phases for the production of recombinant protein drugs, other biotherapeutics and biosimilars”, comments Dr. Thomas Schwarz, CEO of instrAction.

“In order to exploit the full value of this exciting new protein purification technology and to convince customers from pharma process development and production, it is important to provide convincing data sets from feasibility studies. Protagen has all the tools and know-how to support instrAction on its way to become the leading company in protein separation technology”, underscores Dr. Stefan Müllner, CEO of Protagen.

Facts, background information, dossiers
More about instrAction
More about Protagen
  • News

    Protagen Expands Cooperation with Bayer HealthCare

    Protagen AG and Bayer HealthCare Pharmaceuticals announced the start of a new collaboration project for the clinical validation of diagnostic biomarkers in Endometriosis. This new cooperation project builds on the results of the Endometriosis biomarker discovery study performed last year, a ... more

    Protagen and Charles River Form Strategic Partnership

    Protagen AG and Charles River Laboratories International, Inc. are announce a strategic Marketing & Sales alliance. For Charles River Biopharmaceutical Services (BPS) the fast-growing demand for biopharmaceuticals testing requires an expert partner with a broad range of services. Charles Ri ... more

    Protagen AG and MicroDiscovery GmbH cooperate in biomarker development

    Dortmund based Protagen AG and MicroDiscovery GmbH, a bioinformatics company based in Berlin, have started a cooperation to identify and validate biomarkers for medically relevant diseases. „Our proprietary technology platform UNIarray® and MicroDiscovery’s certified software solutions for ... more

  • Companies

    Protagen AG

    Protagen AG is an international leading specialist in the fields of molecular diagnostics and GMP-compliant protein analysis of biotherapeutics. Our long experience in business and the comprehensive, validated spectrum of analytical methods for registration ensure highest quality to custome ... more